Postgraduate Year Two (PGY2)
The oncology residency program at the Huntsman Cancer Institute (HCI) at the University of Utah is an intensive one-year clinical training program. HCI is an academic National Cancer Institute (NCI)-designated comprehensive cancer center and National Comprehensive Cancer Center (NCCN) member institution. The resident will develop an extensive knowledge base and problem-solving skills through an array of clinical experiences in acute and ambulatory care settings. The resident will be involved in maintaining and improving oncology practice by providing pharmacy services in various areas. Upon completion of the residency, the resident will be well prepared to practice in a variety of oncology settings. The program is accredited by the American Society of Health-System Pharmacists.
- Demonstrate a high level of professional responsibility, dedication, skill and maturity to practice in an oncology clinical environment.
- Develop a working knowledge of the biology of neoplasia which is evolving medication therapy in the field of oncology.
- Attain a level of didactic knowledge that will enable the resident to pass the Board Certified Oncology Pharmacist (BCOP) exam (with further study of at least statistics, drug literature evaluation, practice management, public health and advocacy concepts likely necessary).
- Serve as a role model and instructor for undergraduate and graduate students, and for practicing pharmacists.
- Demonstrate the motivation and responsibility for self-directed, independent study and learning.
- Clearly, concisely, effectively, and appropriately communicate, both verbally and in writing, with health care professionals and with patients.
- Develop a skill set of practice that assures competent practice in a variety of oncology settings.
Required experiences include inpatient hematology, oncology, and stem cell transplant, outpatient clinics, oncology infusion services, infectious disease, investigational drug services, and management. Electives include oncology-specific intensive care, pain and palliative care, pediatric oncology and stem cell transplant, and drug information among others. See here for further rotation information. See also here for a sample of resident scheduling possibilities, and here for a list of oncology-specific preceptors.
Teaching & Learning Opportunities
The resident will lead a variety of weekly formal topic discussions (6 per resident, in addition to topic discussions on rotation). Each resident will prepare at least 1 hour of content for the college of pharmacy within the oncology pharmacotherapeutics module and is allowed to participate in additional lecture and/or recitation opportunities if interested. Residents participate in weekly discussions regarding the fundamentals of neoplastic disease biology through a methodical review of a biology of cancer textbook. Each resident will prepare and present a 1-hour ACPE-accredited continuing education program. Additional opportunities are available through student and resident precepting and/or mentoring, multidisciplinary in-services, oncology fellows’ conferences, journal clubs, and an optional teaching certificate program.
Each resident will function in a staff pharmacist capacity in both centralized and decentralized areas on an average of 4 shifts per month. Areas that the resident will staff include inpatient hematology, oncology, and stem cell transplant; infusion; and central pharmacy. Additional areas may be included based on resident interest and departmental needs. Residents are required to staff a portion of observed holidays. Participation in various community volunteer opportunities is encouraged, but not required.
All University of Utah residents are expected to attend the ASHP Midyear Clinical Meeting in December and Mountain States Conference in May. PGY2 Oncology residents are also encouraged to attend the HOPA Annual Meeting in March.
Each resident will choose a project idea either of their own creation or as presented by a preceptor as long as the project aligns with our institutional strategic plan and departmental goals, or improves patient care by either answering a clinical question or developing new pharmacy services. All ideas will be vetted through the research subcommittee. Each project will be presented in poster form as the annual Vizient (UHC) meeting prior to Midyear, with an additional optional poster presentation at the HOPA annual meeting. Each resident will present their project findings as a platform presentation at the Mountain States Conference and prepare a manuscript suitable for publication in an appropriate journal.
Candidates must graduate from an ACPE-accredited pharmacy program with a Doctor of Pharmacy degree (or equivalent combination of education and clinical experience). Minimum GPA is not required as for other programs, but is taken into consideration. Residents must also have completed an accredited PGY1 pharmacy residency program. Applicants must be eligible for Utah licensure and are expected to obtain licensure as a pharmacist in Utah within the first 60 days of the start of the program year.
Recruitment and Selection
The following information must be submitted by the date specified (typically January 1) in the Pharmacy Online Residency Centralized Application Service (PhORCAS) for the applicant to be considered for an onsite interview:
- Completed PhORCAS registration
- Curriculum vitae
- Letter of intent
- College of pharmacy transcripts
- Three recommendations using the PhORCAS standard form
All residency programs at University of Utah Health use PhORCAS for application review and do not accept paper applications. Completed applications in PhORCAS are reviewed, and competitive applicants are invited to attend an on-site, full-day interview in January, February, or March. The program participates in the National Matching Service through ASHP.